FRAX®-estimated and observed number of first new fractures during follow-up
| FRAX® without BMD (n=2626) | FRAX® with BMD (n=1986) | |||
| Observed | Estimated (95% CI) | Observed | Estimated (95% CI) | |
| Women | ||||
| MOP | 145 | 97.5 (78.6 to 116.3) | 116 | 91.3 (73.1 to 109.4) |
| Hip | 20 | 30.9 (20.1 to 41.8) | 17 | 35.8 (24.2 to 44.4) |
| Men | ||||
| MOP | 33 | 24.9 (15.3 to 34.6) | 23 | 18.9 (10.6 to 27.2) |
| Hip | 8 | 9.9 (3.82 to 16.1) | 7 | 10.3 (4.1 to 16.5) |
| Women and Men | ||||
| MOP | 178 | 122.4 (101.3 to 143.6) | 139 | 116.2 (95.7 to 136.7) |
| Hip | 28 | 40.9 (28.4 to 53.3) | 24 | 48.7 (35.2 to 62.2) |
| Age <60 years | ||||
| MOP | 69 | 34.7 (23.3 to 46.1) | 52 | 36.8 (25.1 to 48.5) |
| Hip | 1 | 5.5 (0.9 to 10.1) | 1 | 12.4 (5.5 to 19.2) |
| Age 60–75 years | ||||
| MOP | 97 | 67 (51.5 to 82.5) | 77 | 60.4 (45.9 to 75) |
| Hip | 21 | 24.1 (14.6 to 33.7) | 18 | 26.3 (16.5 to 36.1) |
| Age >75 years | ||||
| MOP | 12 | 21 (12.7 to 29.3) | 10 | 13.7 (7.08 to 20.3) |
| Hip | 6 | 11.4 (5.06 to 17.8) | 5 | 7.8 (2.6 to 13) |
BMD, bone mineral density; MOP, major osteoporotic.